The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Cyclopentylethynyl-8-(3-fluoro-phenyl)-9-methyl-9H-purin-6-ylamine ID: ALA299548
PubChem CID: 10688203
Max Phase: Preclinical
Molecular Formula: C19H18FN5
Molecular Weight: 335.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(-c2cccc(F)c2)nc2c(N)nc(C#CC3CCCC3)nc21
Standard InChI: InChI=1S/C19H18FN5/c1-25-18(13-7-4-8-14(20)11-13)24-16-17(21)22-15(23-19(16)25)10-9-12-5-2-3-6-12/h4,7-8,11-12H,2-3,5-6H2,1H3,(H2,21,22,23)
Standard InChI Key: JZGOLBTTWAAMMN-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
6.5292 -6.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1000 -6.6167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5292 -5.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4417 -6.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1000 -5.6500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -6.7375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -5.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4917 -5.8417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4917 -6.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9625 -6.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0417 -6.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4292 -7.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3667 -5.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0250 -4.9375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2917 -7.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9667 -5.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9042 -7.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3042 -5.1875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.3167 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9167 -6.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2417 -6.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3542 -7.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8250 -7.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -8.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -7.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 1 0
5 3 1 0
6 1 2 0
7 3 2 0
8 9 2 0
9 6 1 0
10 9 1 0
11 4 1 0
12 10 3 0
13 11 1 0
14 7 1 0
15 2 1 0
16 13 2 0
17 12 1 0
18 16 1 0
19 11 2 0
20 19 1 0
21 20 2 0
22 17 1 0
23 17 1 0
24 23 1 0
25 22 1 0
5 4 2 0
8 7 1 0
21 16 1 0
24 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 335.39Molecular Weight (Monoisotopic): 335.1546AlogP: 3.29#Rotatable Bonds: 1Polar Surface Area: 69.62Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.68CX LogP: 4.69CX LogD: 4.69Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -0.78
References 1. Harada H, Asano O, Hoshino Y, Yoshikawa S, Matsukura M, Kabasawa Y, Niijima J, Kotake Y, Watanabe N, Kawata T, Inoue T, Horizoe T, Yasuda N, Minami H, Nagata K, Murakami M, Nagaoka J, Kobayashi S, Tanaka I, Abe S.. (2001) 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor., 44 (2): [PMID:11170626 ] [10.1021/jm990499b ]